type here...

CATEGORIES

Blood Conditions

LATEST

123Page 3 of 3

TRENDING

EDITORS CHOICE

Artificial Intelligence, Microbiome, and Predicting Liver Disease

Michael Hunter, MD -
Increasing evidence suggests an interplay between the gut microbiome and nonalcoholic fatty liver disease (NAFLD). The role of the microbiome in the early detection of the condition remains unclear.

Blood Suggests Higher Cancer Risk

Michael Hunter, MD -
PLATELETS COUNTS APPEAR TO BE DIRECTLY involved with cancer, suggests a growing body of laboratory research. A new study now shows elevated platelet levels associated...

Quitting Alcohol Drops Your Cancer Risk, Right? Not So Fast.

Michael Hunter, MD -
THERE IS NOT STRONG EVIDENCE TO PROVE THAT CUTTING DOWN (or completely stopping) alcohol intake will significantly reduce the risk of most cancers. Yes, I, too,...

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories